TY - JOUR
T1 - Expert consensus document
T2 - Advances in the physiological assessment and diagnosis of GERD
AU - Savarino, Edoardo
AU - Bredenoord, Albert J.
AU - Fox, Mark
AU - Pandolfino, John E.
AU - Roman, Sabine
AU - Prakash Gyawali, C.
N1 - Funding Information:
E.S. has served as consultant for Medtronic and Sandhill Scientific. A.B. received research funding from Endostim, as well as speaker and consulting fees from Medical Measurement Systems. M.F. received research funding from AstraZeneca, Medtronic and Reckitt Benckiser, and educa‑ tional grants or speaker fees from Medical Measurement Systems, Medtronic, Mui Scientific, Reckitt Bencki and Sandhillser. J.E.P. has served as a consultant and speaker for Medtronic and Sandhill Scientific, a speaker for Astra Zeneca and Takeda, and a consultant for Ironwood. He also has stock options from Trimedyne Inc. S.R. has served as consultant for Medtronic and Sandhill Scientific and received research grant from Crospon. C.P.G. has served as a consultant for Ironwood, Medtronic and Torax, he is a speaker for Allergan and Medtronic, and has received research funding from Medtronic.
Publisher Copyright:
© 2017 Macmillan Publishers Limited, part of Springer Nature.
PY - 2017/11/1
Y1 - 2017/11/1
N2 - GERD is a common condition worldwide. Key mechanisms of disease include abnormal oesophagogastric junction structure and function, and impaired oesophageal clearance. A therapeutic trial of acid-suppressive PPI therapy is often the initial management, with endoscopy performed in the setting of alarm symptoms and to exclude other conditions. If symptoms persist and endoscopy does not reveal evidence of GERD, oesophageal function tests are performed, including oesophageal manometry and ambulatory reflux monitoring. However, reflux episodes can be physiological, and some findings on endoscopy and manometry can be encountered in asymptomatic individuals without GERD symptoms. The diagnosis of GERD on the basis of functional oesophageal testing has been previously reported, but no updated expert recommendations on indications and the interpretation of oesophageal function testing in GERD has been made since the Porto consensus over a decade ago. In this Consensus Statement, we aim to describe modern oesophageal physiological tests and their analysis with an emphasis on establishing indications and consensus on interpretation parameters of oesophageal function testing for the evaluation of GERD in clinical practice. This document reflects the collective conclusions of the international GERD working group, incorporating existing data with expert consensus opinion.
AB - GERD is a common condition worldwide. Key mechanisms of disease include abnormal oesophagogastric junction structure and function, and impaired oesophageal clearance. A therapeutic trial of acid-suppressive PPI therapy is often the initial management, with endoscopy performed in the setting of alarm symptoms and to exclude other conditions. If symptoms persist and endoscopy does not reveal evidence of GERD, oesophageal function tests are performed, including oesophageal manometry and ambulatory reflux monitoring. However, reflux episodes can be physiological, and some findings on endoscopy and manometry can be encountered in asymptomatic individuals without GERD symptoms. The diagnosis of GERD on the basis of functional oesophageal testing has been previously reported, but no updated expert recommendations on indications and the interpretation of oesophageal function testing in GERD has been made since the Porto consensus over a decade ago. In this Consensus Statement, we aim to describe modern oesophageal physiological tests and their analysis with an emphasis on establishing indications and consensus on interpretation parameters of oesophageal function testing for the evaluation of GERD in clinical practice. This document reflects the collective conclusions of the international GERD working group, incorporating existing data with expert consensus opinion.
UR - http://www.scopus.com/inward/record.url?scp=85032435815&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032435815&partnerID=8YFLogxK
U2 - 10.1038/nrgastro.2017.130
DO - 10.1038/nrgastro.2017.130
M3 - Article
C2 - 28951582
AN - SCOPUS:85032435815
SN - 1759-5045
VL - 14
SP - 665
EP - 676
JO - Nature Reviews Gastroenterology and Hepatology
JF - Nature Reviews Gastroenterology and Hepatology
IS - 11
ER -